Get started
Author

Kimberly Sue Slade

Observed names: K. Slade, K. Sue Slade, K.S. Slade, Kimberly S. Slade, Kimberly Slade, Slade, K.
OpenAlex ID: A5071897225
Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis
2020 · Sascha D. Markowitsch, Patricia Schupp, et al. · Cancers · 129
PDF
Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction
2020 · Fuguang Zhao, Olesya Vakhrusheva, et al. · Cells · 116
PDF
Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis
2021 · Sascha D. Markowitsch, Kira M. Juetter, et al. · Cancers · 59
PDF
Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells
2022 · Olesya Vakhrusheva, Holger H. H. Erb, et al. · Frontiers in Oncology · 33
PDF
Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway
2022 · Sascha D. Markowitsch, Olesya Vakhrusheva, et al. · Cancers · 26
PDF
Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile Cancer
2022 · Anita Thomas, Kimberly Sue Slade, et al. · Cancers · 12
PDF
Artesunate Inhibits Metastatic Potential in Cisplatin-Resistant Bladder Cancer Cells by Altering Integrins
2025 · Fuguang Zhao, Olesya Vakhrusheva, et al. · Cells · 5
PDF
Correction: Zhao et al. Artesunate Inhibits Metastatic Potential in Cisplatin-Resistant Bladder Cancer Cells by Altering Integrins. Cells 2025, 14, 570
2026 · Fuguang Zhao, Olesya Vakhrusheva, et al. · Cells
PDF
Bedeutung der PARP1–JAK2–STAT3-Signalachse für Progression und Therapieresistenz beim Peniskarzinom
2026 · Thomas, Anita, Slade, K., et al. · German Medical Science (German Research Foundation)
Ip27-27 Targeting the Ubiquitin-proteasome Pathway: Novel Therapeutic Approaches to Overcome Cisplatin Resistance in Penile Cancer
2025 · Anita Thomas, Kimberly Sue Slade, et al. · The Journal of Urology
Ip27-26 Evaluating C-met Inhibitors Tivantinib and Cabozantinib as Novel Therapeutic Options in Penile Cancer
2025 · Anita Thomas, Kimberly Sue Slade, et al. · The Journal of Urology
A0258 – Exploiting the ubiquitin-proteasome pathway: New therapeutic targets for overcoming drug resistance in penile cancer
2025 · A. Thomas, K. Slade, et al. · European Urology
A0257 – Preclinical rationale for targeting c-MET in penile cancer
2025 · I. Tsaur, K. Sue Slade, et al. · European Urology
Preclinical assessment of integrin receptors as therapeutic targets in advanced treatment-resistant prostate cancer
2024 · I. Tsaur, M. Saar, et al. · European Urology
mTOR/AKT pathway: New insights for dianostic and therapeutic care in penile cancer
2023 · O. Vakhrusheva, A. Thomas, et al. · European Urology Open Science
Metastasis of cisplatin-resistant bladder cancer cells is impaired by artesunate through inhibition of integrin subtypes
2022 · O. Vakhrusheva, F. Zhao, et al. · European Urology Open Science
Abstract 5384: Cell growth of sunitinib-resistant renal cell carcinoma was inhibited by Shikonin through necroptosis induction and Akt/mTOR signaling inhibition
2022 · Eva Juengel, Sascha D. Markowitsch, et al. · Cancer Research
Mp46-20 Influence of Resistance to Cisplatin and Osimertinib on Patterns of Metastatic Behavior of Penile Cancer
2022 · Anita Thomas, Shirine Huck, et al. · The Journal of Urology
Impact of resistance to cisplatin and osimertinib on dissemination properties of penile cancer cells
2022 · A. Thomas, S. Huck, et al. · European Urology
Artesunate inhibits the progressive growth behavior of docetaxel-resistant prostate cancer cells
2021 · E. Jüngel, O. Vakhrusheva, et al. · European Urology Open Science
Works count: 28
Citation count: 380
H-index: 6
I10-index: 6
Year
Topic
Type